In this study, it is aimed to compare the lesion location, lesion size, local and distant metastases detection rates of Ga68 PSMA PET and Multiparametric Prostate MR imaging tests used in staging in patients diagnosed with prostate cancer. The pathologies of the patients who were decided to undergo radical prostatectomy as a treatment will also be compared with the staging tests.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Enrollment
47
Comparison of Ga68 PSMA PET and Multiparametric Prostate MR imaging tests used in staging in patients diagnosed with prostate cancer
Gulhane Research and Training Hospital
Ankara, Etlik, Turkey (Türkiye)
RECRUITINGLesion location
Both MRI and PET results will be compared. Lesion location will be defined as "left", "right", "apical", "basal", "midline".
Time frame: Between prostate biopsy and curative treatment decision , usually 2 month
Lesion Size
Both MRI and PET results will be compared, Lesion size will be stated in milimeters.
Time frame: Between prostate biopsy and curative treatment decision , usually 2 month
Lymph node involvement
Both MRI and PET results will be compared. Involvement will be stated as "exist", "non-exist".
Time frame: Between prostate biopsy and curative treatment decision , usually 2 month
Extraprostatic involvement
Both MRI and PET results will be compared. Involvement will be stated as "exist" , "non-exist".
Time frame: Between prostate biopsy and curative treatment decision , usually 2 month
Local and distant metastasis
Both MRI and PET results will be compared. Metastasis will be stated as "exist" , "non-exist".
Time frame: Between prostate biopsy and curative treatment decision , usually 2 month
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.